Community Science Alliance

iPaths

Adult Community Acquired Pneumonia

This pathway is used to treat Adult Community Acquired Pneumonia in resource limited settings.

Adult Undifferentiated Acute Fever

Pathway for the diagnosis and management of Adult Acute Undifferentiated Fever (AUF) in India

Anaemia

CSA pathway for the diagnosis and management of anaemia in India and other resource-limited settings

Asthma

Pathway for the diagnosis and management of Asthma in India NOTE: This pathway is not applicable for patients 0 – 5 years old

Chest Pain

This pathway is designed to facilitate chest pain assessment and management in rural primary care settings

Chronic Obstructive Pulmonary Disease (COPD)

CSA pathway for the diagnosis and management of COPD in India and other resource-limited settings

Diabetic Foot Ulcer (DFU)

Pathway for the screening and management of diabetic foot pathway (DFU) in diabetic patients in India

Diarrhoea

This pathway is used to evaluate and treat adult diarrhoea in low resource settings.

Heart Failure

This Heart Failure Pathway is to be used in conjunction with other pathways to assess and manage comorbidities. NOTE: Pregnant patients require pregnancy specific management – DO NOT use this pathway for pregnant patients.

Snake Bite

NHSRC Standard Treatment Guideline for Snakebite in India

Stroke

A pathway for the assessment and management of Stroke at a Community health center

Acute Bacterial Osteomyelitis

Empirical treatment regimens for Acute Bacterial Osteomyelitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Acute Bacterial Osteomyelitis.

Acute Infectious Diarrhoea/ Gastroenteritis

Empirical treatment regimens for Acute Infectious Diarrhoea/ Gastroenteritis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Acute infectious diarrhoea/ gastroenteritis cases.

Acute Otitis Media

Empirical treatment regimens for Acute otitis media based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Acute otitis media.

Acute Sinusitis

Empirical treatment regimens for Acute sinusitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Acute sinusitis.

Bacterial Eye Infections (Excluding Trachoma)

Empirical treatment regimens for Bacterial eye infections (excluding trachoma) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Bacterial eye infections (excluding trachoma).

Bacterial Meningitis

Empirical treatment regimens for bacterial meningitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover assessment and management of suspected bacterial meningitis.

Bronchitis

Empirical treatment regimens for bronchitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected bronchitis.

Burn Wound-related Infections

Empirical treatment regimens for Burn Wound-related Infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Burn wound-related infections.

Chlamydial Urogenital Infection

Empirical treatment regimens for Chlamydial urogenital infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Chlamydial urogenital infections.

Community Acquired Pneumonia (Mild)

Empirical treatment regimens for Community acquired pneumonia (mild) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Community acquired pneumonia (mild).

Community-acquired Pneumonia – Severe

Empirical treatment regimens for Community-acquired Pneumonia – Severe based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Community-acquired Pneumonia – Severe cases.

COPD Exacerbation

Empirical treatment regimens for COPD Exacerbation based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of COPD Exacerbation.

Enteric Fever

Empirical treatment regimens for Enteric Fever based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Enteric Fever.

Febrile Neutropenia

Empirical treatment regimens for Febrile Neutropenia based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Febrile Neutropenia.

Gonococcal

Empirical treatment regimens for Gonococcal infection- sexually transmitted infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Gonococcal infection- sexually transmitted infections.

Hospital-acquired Pneumonia

Empirical treatment regimens for Hospital-acquired Pneumonia based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Hospital-acquired pneumonia cases.

Impetigo / Erysipelas / Cellulitis -Skin and soft tissue infection

Empirical treatment regimens for Impetigo / Erysipelas / Cellulitis -Skin and soft tissue infection based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Impetigo / Erysipelas / Cellulitis–Skin and soft tissue infection.

Intra-abdominal Infections – Acute Appendicitis

Empirical treatment regimens for Intra-abdominal Infections – Acute Appendicitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Intra-abdominal infections – acute appendicitis cases.

Intra-abdominal Infections – Acute Cholecystitis and Cholangitis

Empirical treatment regimens for Intra-abdominal Infections – Acute Cholecystitis and Cholangitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected acute cholecystitis and cholangitis cases.

Intra-abdominal Infections – Acute Diverticulitis

Empirical treatment regimens for Intra-abdominal Infections – Acute Diverticulitis in adults based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Intra-abdominal Infections – Acute Diverticulitis cases.

Intra-abdominal Infections – Clostridioides Difficile Infection

Empirical treatment regimens for Intra-abdominal Infections – Clostridioides difficile infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Clostridioides difficile infection.

Intra-abdominal Infections – Pyogenic Liver Abscess

Empirical treatment regimens for Intra-abdominal Infections – Pyogenic Liver Abscess based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Intra-abdominal infections – pyogenic liver abscess cases.

Localized Acute Bacterial Lymphadenitis

Empirical treatment regimens for Localized acute bacterial lymphadenitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Localized acute bacterial lymphadenitis.

Lower Urinary Tract Infection

Empirical treatment regimens for Lower urinary tract infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Lower urinary tract infections.

Necrotizing Fasciitis

Empirical treatment regimens for Necrotizing Fasciitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Necrotizing Fasciitis.

Oral and dental infections

Empirical treatment regimens for Oral and dental infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Oral and dental infections.

Pharyngitis

Empirical treatment regimens for Pharyngitis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected pharyngitis.

Pyomyositis

Empirical treatment regimens for Pyomyositis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Pyomyositis.

Sepsis in Adults (Including Septic Shock)

Empirical treatment regimens for Sepsis in Adults (Including Septic Shock) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Sepsis in adults (including septic shock).

Sepsis in Neonates and Children

Empirical treatment regimens for Sepsis in Neonates (< 28 days) and Children (28 days–12 years) based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Sepsis in Neonates and Children.

Septic Arthritis

Empirical treatment regimens for Septic Arthritis based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Septic Arthritis.

Snake Bite

NHSRC Standard Treatment Guideline for Snakebite in India

Surgical Prophylaxis

Prevention of infectious complications by administering an effective antibiotic before exposure to contamination during surgery. Source: WHO

Syphilis

Empirical treatment regimens for Syphilis- sexually transmitted infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Syphilis- sexually transmitted infections.

Trachoma

Empirical treatment regimens for Trachoma based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Trachoma.

Trichomoniasis

Empirical treatment regimens for Trichomoniasis- sexually transmitted infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Trichomoniasis- sexually transmitted infections.

Upper Urinary Tract Infection

Empirical treatment regimens for Upper Urinary Tract Infection based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of Upper Urinary Tract Infection.

Wound and Bite-related Infections

Empirical treatment regimens for Burn Wound and bite-related infections based on the WHO Antibiotic Book (2022). This pathway does NOT cover the assessment and management of suspected Wound and bite-related infections.